ImmunoGen
IMGN
$4.29
Share price
-0.12%
Change (1 day)
-36.54%
Change (1 year)
Categories
Market capitalization of ImmunoGen (IMGN)
Market cap: $0.94 Billion
As of June 2022 ImmunoGen has a market cap of $0.94 Billion. This makes ImmunoGen the world's 4348th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ImmunoGen from 2001 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.95 B | -41.8% |
| 2021 | $1.63 B | 30.04% |
| 2020 | $1.25 B | 63.86% |
| 2019 | $0.76 B | 6.88% |
| 2018 | $0.71 B | -15.41% |
| 2017 | $0.84 B | 376% |
| 2016 | $0.17 B | -84.92% |
| 2015 | $1.18 B | 124.94% |
| 2014 | $0.52 B | -58.2% |
| 2013 | $1.25 B | 17.03% |
| 2012 | $1.07 B | 21.27% |
| 2011 | $0.88 B | 40.52% |
| 2010 | $0.62 B | 39.84% |
| 2009 | $0.45 B | 106.73% |
| 2008 | $0.21 B | 22.39% |
| 2007 | $0.17 B | -15.67% |
| 2006 | $0.21 B | 0.18% |
| 2005 | $0.21 B | -41.61% |
| 2004 | $0.36 B | 76.06% |
| 2003 | $0.20 B | 56.69% |
| 2002 | $0.13 B | -80.16% |
| 2001 | $0.65 B |
End of Day market cap according to different sources
On Jun 28th, 2022 the market cap of ImmunoGen was reported to be:
$0.94 Billion
$0.94 Billion
$0.94 Billion
$0.95 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $467.59 B | 49,381.63% | 🇺🇸 USA |
 Novartis NVS | $189.47 B | 19,950.77% | 🇨🇭 Switzerland |
 Pfizer PFE | $286.12 B | 30,178.18% | 🇺🇸 USA |
 Eli Lilly LLY | $306.52 B | 32,336.26% | 🇺🇸 USA |
 Amgen AMGN | $131.22 B | 13,786.42% | 🇺🇸 USA |
 Sanofi SNY | $132.79 B | 13,952.42% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $166.69 B | 17,539.72% | 🇺🇸 USA |
 Seagen
SGEN | $33.01 B | 3,393.85% | 🇺🇸 USA |